These blood thinners may have an unexpected benefit for Alzheimer’s patients

Data ReadoutpositiveNOACsWarfarinPositive

AI Analysis

Summary

Researchers found that patients with Alzheimer's disease taking NOACs (newer anticoagulants) experienced slower cognitive decline compared to those using warfarin or no blood thinners, suggesting an unexpected therapeutic benefit beyond stroke prevention.

Outcome Details

NOACs associated with slower cognitive decline compared to warfarin or no blood thinners in Alzheimer's patients

Importance:5/10

Sentiment:

0.60

NOACsAlzheimer's diseaseatrial fibrillationcognitive declineanticoagulationresearch findings

Read the original article

Published by ScienceDaily Pharmaceuticals on September 18, 2026 9:48 AM

Read Original